WES and targeted sequencing of venetoclax-resistant CLL revealed the presence of mutations affecting pro-apoptotic BCL2 family members (BAD, BAX, and NOXA) [132,133]. Here, BCL2 is linked to B-cell chronic lymphocytic leukemia.